Asthma not helped by a new inhaler
PLAB 2 practice station

Counselling & explanation · 1 min to read · 8 min to perform

Try a real conversation · PLAB 2AI practice

Ms Lorraine Pickford, aged 38, has asthma and was prescribed a regular beclometasone preventer inhaler three months ago.

Lorraine PickfordHello doctor. That brown inhaler you gave me isn't doing anything. I'm still wheezing and coughing at night.

Free · no sign-up · uses your one free station

The task

You are a GP. Ms Lorraine Pickford, aged 38, has asthma and was prescribed a regular beclometasone preventer inhaler three months ago. She says it is not helping. She is alone. Find out how she is using her inhalers, explain why and how the preventer should be used, and agree a plan. The examiner will not take part in the conversation.

Answer for this station

What a strong answer does

  • Introduces self, confirms identity and explores her understanding and concerns about asthma and inhalers.
  • Establishes asthma control: night symptoms, exercise limitation, work, reliever use and exacerbations.
  • Clarifies adherence and reasons: finds that she uses the preventer only when wheezy and fears steroid side effects.
  • Asks about and observes inhaler technique, including spacer use, and identifies errors without blame.
  • Explains the difference between preventer and reliever in simple terms: the preventer reduces inflammation and works only with daily use, the reliever relaxes airways.
  • Teaches correct technique: shake, spacer, one puff at a time, slow breath in, hold breath for about 10 seconds, wait and repeat; rinse mouth after.
  • Addresses concerns about steroids: inhaled doses are low and local, side effects like hoarseness and thrush are reduced by a spacer and rinsing.
  • Safety: Advises on a self-management plan: daily preventer, when to use the reliever, trigger avoidance, vaping, and when to seek urgent help.
  • Arranges follow-up in 4 to 6 weeks with a written action plan, explains that a combined preventer and reliever inhaler (MART) is the next step if control is still poor despite good use, and checks understanding with teach-back.

Model answer

I introduce myself, confirm Ms Pickford’s identity and ask how she uses her inhalers. She takes the brown beclometasone preventer irregularly and uses the blue reliever three or four times a day. She wakes at night twice a week and has missed work. She believes the preventer is like a reliever and fears steroid side effects. I explore triggers and note vaping, a cat and hay fever. I ask her to demonstrate her technique. She does not shake the inhaler, uses no spacer, presses and inhales quickly, and does not hold her breath. Her peak flow is 360 L/min against a best of 470 and there is mild wheeze. I conclude that her asthma is poorly controlled because of poor adherence and technique, not because the medicine has failed. I explain without blame that the preventer reduces airway inflammation and must be taken every day to work, while the reliever only relieves symptoms briefly. I demonstrate the technique: shake, attach the spacer, one puff, a slow breath, hold for about ten seconds, and rinse the mouth afterwards. I address concerns about steroids, explaining that inhaled doses are low, act locally and have fewer risks than tablets, and that a spacer and rinsing reduce hoarseness and thrush. I advise stopping vaping. I agree a written personal asthma action plan and explain when to seek urgent help: contact us the same day if she needs the reliever more than usual, and call 999 if it gives no relief or she cannot speak in full sentences. I arrange a review in four to six weeks and explain that if control is still poor despite daily use and good technique, the next step is a combined preventer and reliever inhaler (MART), ask her to repeat the technique to check understanding, and document.

What this station tests

  • Poor control with a preventer often reflects adherence and technique, not drug failure.
  • Ask the patient to demonstrate technique rather than assuming it is correct.
  • Explain preventer versus reliever using plain language.
  • Address steroid fears directly and respectfully.
  • Give a written personal asthma action plan and book a review.
  • If asthma stays uncontrolled despite good adherence and technique, NICE NG245 advises moving to MART.

Sources for the clinical content

An original practice scenario with invented patients. Not an exam question. Written from the guidance above and reviewed before release: how we write and check stations.

Practise next

About the PLAB 2 →